Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

MASTER I - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients

ClinicalTrials.gov ID: NCT00305240

Public ClinicalTrials.gov record NCT00305240. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 4:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients (MASTER I)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to determine the usefulness of microvolt T wave alternans (MTWA) testing of patients that have had a heart attack and have decreased pumping ability of the lower chamber of their heart. MTWA testing is a non-invasive test used to detect the likelihood of developing abnormally fast rhythms in the lower chambers of the heart. The objective of the study is to prove that if a patient has a negative MTWA test, they will be less likely to develop abnormally fast and dangerous rhythms in the lower chambers of the heart. The results of the study will help doctors to determine which patients would benefit the most from having an Implantable Cardioverter Defibrillator (ICD) implanted.

Study identification

NCT ID
NCT00305240
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Enrollment
656 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2003
Primary completion
Jan 31, 2007
Completion
Jan 31, 2007
Last update posted
Feb 12, 2008

2003 – 2007

United States locations

U.S. sites
47
U.S. states
26
U.S. cities
47
Facility City State ZIP Site status
Not listed Mobile Alabama
Not listed Phoenix Arizona
Not listed Walnut Creek California
Not listed Denver Colorado
Not listed Hartford Connecticut
Not listed Hollywood Florida
Not listed Naples Florida
Not listed Safety Harbor Florida
Not listed Atlanta Georgia
Not listed Joliet Illinois
Not listed Springfield Illinois
Not listed Beech Grove Indiana
Not listed Kansas City Kansas
Not listed New Orleans Louisiana
Not listed Hyannis Massachusetts
Not listed Grand Rapids Michigan
Not listed Saginaw Michigan
Not listed Saint Joseph Michigan
Not listed Minneapolis Minnesota
Not listed Omaha Nebraska
Not listed Las Vegas Nevada
Not listed East Islip New York
Not listed Flushing New York
Not listed West Islip New York
Not listed Gastonia North Carolina
Not listed Greensboro North Carolina
Not listed High Point North Carolina
Not listed Raleigh North Carolina
Not listed Cincinnati Ohio
Not listed Cleveland Ohio
Not listed Columbus Ohio
Not listed Toledo Ohio
Not listed Doylestown Pennsylvania
Not listed Philadelphia Pennsylvania
Not listed Pittsburgh Pennsylvania
Not listed Scranton Pennsylvania
Not listed Spartanburg South Carolina
Not listed Chattanooga Tennessee
Not listed Germantown Tennessee
Not listed Amarillo Texas
Not listed Corpus Christi Texas
Not listed Plano Texas
Not listed Tyler Texas
Not listed Burlington Vermont
Not listed Chesapeake Virginia
Not listed Portsmouth Virginia
Not listed Appleton Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00305240, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 12, 2008 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00305240 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →